Patents by Inventor Cornelia Daehnrich

Cornelia Daehnrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200191785
    Abstract: A method is useful for diagnosing AIG, which includes the step of detecting whether autoantibodies against the beta-subunit of the gastric H+/K+-ATPase are present or not in a sample comprising antibodies. The method utilizes a diagnostically useful carrier that contains a solid phase on which an agent for the specific capture of the autoantibody is immobilized. Furthermore, the diagnostically useful carrier includes a solid phase on which an agent for the specific capture of an autoantibody against the beta-subunit of the gastric H+/K+-ATPase is immobilized.
    Type: Application
    Filed: November 18, 2019
    Publication date: June 18, 2020
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Cornelia Daehnrich, Christian Probst, Lars Komorowski
  • Patent number: 8124354
    Abstract: The present invention relates to fusion peptides that are derived from components of gliadin, to a method and reagents for the serological diagnosis of celiac disease or dermatitis herpetiformis by way of assaying antibodies that are directed against modified gliadin. The invention also relates to methods and pharmaceutical compositions for treating said diseases by specific immunoabsorption of these antibodies.
    Type: Grant
    Filed: April 25, 2008
    Date of Patent: February 28, 2012
    Assignee: Euroimmun Medizinische Labordiagnostika AG
    Inventors: Christian Probst, Wolfgang Schlumberger, Winfried Stöcker, Cornelia Dähnrich, Lars Komorowski, Thomas Mothes
  • Publication number: 20100203558
    Abstract: The present invention relates to fusion peptides that are derived from components of gliadin, to a method and reagents for the serological diagnosis of celiac disease or dermatitis herpetiformis by way of assaying antibodies that are directed against modified gliadin. The invention also relates to methods and pharmaceutical compositions for treating said diseases by specific immunoabsorption of these antibodies.
    Type: Application
    Filed: April 25, 2008
    Publication date: August 12, 2010
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Christian Probst, Wolfgang Schlumberger, Winfried Stöcker, Cornelia Dähnrich, Lars Komorowski, Thomas Mothes
  • Patent number: 7566545
    Abstract: Compositions and methods are provided for decreasing blood glucose levels in an animal or for preventing or delaying the onset of a rise in blood glucose levels in an animal, comprising administering to the animal an antisense inhibitor of PTP1B expression in combination with at least one glucose-lowering drug. The present invention is also directed to compositions and methods for improving insulin sensitivity in an animal or for preventing or delaying the onset of insulin resistance in an animal. Also provided are compositions and methods for treating or preventing a metabolic condition in an animal. The metabolic condition may be, e.g., diabetes or obesity.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: July 28, 2009
    Assignee: Euroimmun Medizinische Labordiagnostika AG
    Inventors: Waltraud Suer, Cornelia Dähnrich, Wolfgang Schlumberger, Winfried Stöcker